CCA has partnered with the Gastroenterological Society of Australia (GESA) and Australian General Practice Accreditation Limited (AGPAL) to support general practitioners to participate in IBD management more effectively through awareness, education, and Continuing Professional Development (CPD).
IBD is increasing in prevalence in Australia and it is estimated that the prevalence of IBD will increase to 100,000 by 2022. Currently many patients with IBD receive suboptimal care. To assist healthcare professionals in the management of IBD, this centralised webpage aims to provide GPs, general gastroenterologists, general physicians and allied healthcare professionals with high quality guidelines and tools.
|Resource||Organisation responsible||About resource|
|NEW: IBD for GPs and Physicians||CCA, GESA, AGPAL||IBD for GPs and Physicians is designed to provide general practitioners, general physicians, gastroenterologists and surgeons with IBD-specific foundational and advanced knowledge that can be applied in practices. Create an account to access learning materials which includes:|
– Online self-directed modules*
*Self-directed modules and workshops have CPD points allocated
|Inflammatory Bowel Disease (IBD)||GESA||The IBD Australian Guidelines for GPs and Physicians provides a general guide to appropriate practice. The guidelines are designed to provide information to assist in decision making.|
|NEW: Management Overview of Inflammatory Bowel Disease||GESA||2 page summary of IBD Guidelines (GESA) above. |
Developed as part of the GP Aware Project.
|Inflammatory Bowel Disease (IBD) in PregnancyGE Fact Sheet (GESA)GP and Obstetrician Fact Sheet (GESA)Medication Fact Sheet||GESA||Factsheets to aid clinicians in the management of pregnancy and fertility in IBD. Includes IBD medications that are safe during pregnancy and lactation.|
|IBS4GPs Diagnostic Online Tool for GPs||GESA||The online tool provides a way for GPs to appropriately assess IBS symptoms, make a confident diagnosis and provide effective treatment.|
|TDM of Anti-Tumour Necrosis Factor Therapy in IBD Consensus Statements||GESA||A wall chart for medical practitioners outlining algorithms for the interpretation of therapeutic drug monitoring results.|
|Faecal Calprotectin in Inflammatory Bowel Disease (IBD)||NPS MedicineWise||Tool provides information about faecal calprotectin and when to use it in IBD patient decision making.|
|Differentiating between IBS and IBD||CCA||Guide for clinicians and patients on distinguishing between IBS and IBD.|
|Clinician’s guide to ulcerative colitis management||CCA||Guide for clinicians on managing ulcerative colitis.|
|My gut feeling – Patient guide for ulcerative colitis||CCA||Guide for patients on managing ulcerative colitis.|
If you are a person with IBD or carer, you can share these resources with your GP or other healthcare professional.
Additional education and training resources for GPs and other clinicians will be available on this page in the future.